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Supplementary Figure S1: The step-by-step data collection process and their sources to develop 
miRegulome v1.0. 
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Supplementary Figure S2: The home page of miRegulome v1.0. The page provides the database 
content statistics in graphical format and also the direct links to chemical-based search. 
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Supplementary Figure S3: Tabular form of chemical-miRNA relationships. Manual curation of  (i) 
chemical(s) (ii) miRNAs responding to the chemical(s), (iii) species of the miRNAs, (iv) expression of 
the miRNAs (up-/down-regulation) in response to the chemical(s), (v) experimental conditions, and (vi) 
techniques used to detect the expression levels of miRNAs. The corresponding PubMed ID from which 
the experimentally validated data are curated is also mentioned. The chemical is hyperlinked to 
Comparative Toxicogenomics Database (CTD), miRNAs hyperlinked to miRBase, and PMID is 
hyperlinked to corresponding NCBI PubMed.  
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Supplementary Figure S4: Tabular form of miRNA hsa-mir-21 and its relationships with (A) 
upstream TF regulators, (B) validated targets, (C) top/prioritized targets, function (BP) of miRNA, (E) 
disease involvement, and (F) pathways in which the miRNA is involved. Clicking on a miRNA in the 
last column i.e. “miRNA Details” of the Supplementary Figure S3 will give this information along 
with PMIDs and appropriate external database links to corresponding module.  
 
 
 
 
Supplementary Figure S5: The design/schema of miRegulome v1.0 database 
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Supplementary Figure S6: The advanced search option of miRegulome v1.0.  Twelve modules  can be 
searched in combination to obtain specific relationships in a miRNA regulome. 
 
 
 
 
Supplementary Figure S7: Method used in chemical-disease analysis tool. Chemicals are generally 
upstream regulators in a miRNA. miRegulome has curated the PubMed literature citing chemical-
miRNA relationships. miRNAs also are significantly up/down regulated in diseases. This analysis tool, 
allows the user to explore the associations between a chemical to disease via miRNAs. When a user 
selects a particular chemical, the tool retrieves all the miRNAs associated with the chemical. 
Thereafter, the tool retrieves all the diseases in which the miRNAs are regulated. In this figure, if a user 
selects chemical ‘C2’ in the Chemical-Disease analysis tool, miRNAs M1 and M3 are retrieved and 
subsequently, their associated diseases, D1, D2 and D3 are retrieved. Finally, the tool shows the top 
diseases in which, these miRNAs (which are associated with the chemical) have been regulated the 
most. It does not assert a direct link between the chemical to a disease via the miRNA, rather allows the 
user to explore and test their hypothesis for indirect associations between the chemical and the disease 
via the miRNA, by observing the diseases and their subsequent regulations. 
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Supplementary Figure S8: The miRNA-Disease association tool in miRegulome v1.0. Human miR-1, 
miR-134, miR-186, miR-208, miR-223, and miR-499 are deregulated in Acute myocardial infarction 
(PMID: 23641832). When this set of miRNA is used for analysis, the tool ranks Myocardial infarction 
at rank-2 with count of PMIDs- 6, and Z-score 4.222. The BPs ranked by the tool also correlate with 
the diseases.  
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Supplementary Figure S9: Method used in Gene-disease analysis tool. When a list of downstream 
target genes is entered by user in the input field, the tool searches for miRNAs associated, within the 
set of genes and counts the number of gene-miRNA associations (i.e. PubMed IDs) recorded in the 
database. Thereafter, the tool searches and counts the existing relationships (i.e. PubMed IDs) between 
the observed miRNAs and diseases in which they are regulated, in the database. Following which, the 
tool ranks the diseases based on their count of PubMed entries, as explained in the Figure. The input set 
of target genes is G1-G5. The tool pulls up the network of associations between genes (G1-G5) --> 
 miRNAs (M1-M5) --> diseases (D1, D3, D4, D5), where the edge denotes association and regulation 
and the edge weight denotes the number of unique PubMed IDs supporting it. Thereafter, the tool 
calculates each gene’s indirect association to diseases via the miRNA by counting the unique PubMed 
IDs, as seen in the tabular calculation in the Figure. Consider Gene G3, which is a target gene for 
miRNA M3 and M4. The number of PubMed IDs supporting these associations is 1 and 6 respectively. 
Thereafter, the tool searches for diseases in which these miRNAs M3 and M4 are regulated. The 
disease is D4, with the number of unique PubMed IDs supporting it, being 1 and 5 by M3 and M4, 
respectively. This calculation is done for all genes. Finally, based on the cumulative counts 
contributing to the association/regulation between miRNA-Disease, a sorted list of diseases is 
generated. The list of diseases suggest that, given the list of input target genes and the corresponding 
miRNAs involved therein, it is plausible that these diseases would have highest regulation of the 
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miRNAs and genes in them. In this Figure, disease D4, has the highest count of PubMed IDs 
contributing to the association/regulation of given target genes, and the miRNAs involved therein, 
based on the generated network. The tool does not assert a relationship between the entered target 
genes and diseases. It is left to the user to investigate it further, using other tools, such as Analysis tool, 
when species of miRNA, tissue, gene name and disease name can be entered to decipher any 
relationships. The tool merely highlights the top diseases indirectly associated with the genes entered, 
via the miRNAs. 
 
Supplementary Table S1: Evaluation of miRNA-Disease tool of miRegulome v1.0 using ten sets of 
miRNAs for various diseases taken from ten different PubMed articles that are not incorporated for this 
version of miRegulome. Out of ten tested miRNA sets, in 8 cases (not highlighted), the PubMed 
mentioned diseases corresponding to the miRNA sets are ranked within the  top 10.  
 
 
PMIDs Set of human miRNAs Disease 
association in 
PMID 
miRegulome 
tool 
miRegulome 
predictions 
miRegulome 
ranks 
miRegulome 
Association 
scores 
Z-scores 
23196705 
 
miR-18a, miR-19a, miR-20a, 
miR-30a, miR-103b, miR-126, 
miR-192, miR-1287 
 
Breast cancer miRNA-
Disease 
Breast cancer 4 4 -0.511 
22213236 
 
miR-21, miR-31, mir-122, 
miR-221, miR-222, miR-145, 
miR-146a, miR-200c, miR-223 
Hepatocellular 
carcinoma 
 miRNA-
Disease 
Hepatocellular 
carcinoma 
3 50 37.821 
23391324 let-7d, miR-150, miR-339, 
miR-342, let-7b, miR-523 
 
Acute myeloid 
leukemia 
miRNA-
Disease 
Acute 
lymphoblastic 
leukemia 
14 2 -0.696 
23272653 miR-182, miR-200a, miR-
200b, miR-200c 
 
Serous 
epithelial 
ovarian cancer 
miRNA-
Disease 
Ovarian 
cancer 
2 16 7.050 
23178446 miR-122, miR-141, miR-155, 
miR-184, miR-200c, miR-210, 
miR-224,miR-514 
Clear cell renal 
cell 
carcinomas   
miRNA-
Disease 
Kidney cancer 10 8 -2.784 
23427895 
 
miR-146b, miR-146, miR-221, 
miR-222, miR-375, miR-551b, 
miR-181, miR-99b 
Papillary 
thyroid 
carcinoma 
miRNA-
Disease 
Papillary 
thyroid 
carcinoma  
3 12 5.288 
23207443 miR-21, miR-451, miR-486, 
miR-205, miR-26b 
Lung Cancer miRNA-
Disease 
Lung Cancer 5 20 18.287 
22768114 miR-34a, miR-34b, miR-34c, 
miR-146b, miR-208a, miR-
221, miR-381, miR-125b, miR-
193a, miR-193b, miR-378a 
Myotonic 
Dystrophy 
Type-2 
miRNA-
Disease 
Duchenne 
muscular 
dystrophy 
11 9 -3.132 
23617747 miR-9, miR-200c Metastatic 
Breast cancer 
miRNA-
Disease 
Breast cancer 1 8 6.682 
23641832 miR-1, miR-134, miR-186, 
miR-208, miR-223, miR-499 
Acute 
myocardial 
infarction 
miRNA-
Disease 
Myocardial 
infarction 
2 6 4.222 
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Supplementary Table S2: Comparison of miR-Disease tool of miRegulome v1.0 and TAM 
(http://210.73.221.6/tam). All top 15 diseases ranked by miR-Disease tool are presented for a specific 
set of miRNA that is associated with the specific disease as mentioned in the corresponding PubMed 
literature. In TAM analysis, same sets of miRNAs were used and the diseases ranked by TAM along 
with the p-values are given. The diseases that are associated with the specific miRNA sets (as per the 
PMID) and matched by both the tools are highlighted. Diseases that are ranked within first 10 by the 
miRegulome tool are highlighted with green and that are above this cut-off are highlighted with red.  
 
  
miRegulome (miR-Disease tool) Results and 
Ranks 
TAM  
Results 
PubMed/Disease 
Input miRNAs 
from the PMID 
Diseases 
Ranks 
Z-
scores Diseases Ranks p-values 
23196705                                
Breast cancer 
miR-18a 
miR-19a 
miR-20a 
miR-30a
miR-103b 
miR-126 
miR-192 
miR-1287 
Lung cancer 1 
10.392 
Lung neoplasms 5 2.57E-05 
Colorectal cancer 2 
12.322 
Colorectal neoplasms 37 0.0491 
Hepatocellular carcinoma 3 
8.280 
Carcinoma,Hepatocellular 26 4.57E-03 
Breast cancer 4 -0.511 Breast neoplasms 32 0.0168 
Medulloblastoma 5 
-0.511 
Medulloblastoma 2 1.25E-05 
Prostate cancer 6 
-1.740 
Prostatic neoplasms 62 0.5016 
Glioma 7 
-1.044 
Glioma 36 0.0275 
Anaplastic thyroid carcinoma 8 
-1.044 
NA   
Kidney cancer 9 
-1.044 
NA   
Endometriosis 10 
-1.044 
Endometriosis 33 0.0215 
Acute myeloid leukemia 11 
-1.044 
Leukemia,Myeloid,Acute 15 3.14E-04 
Malignant lymphoma 12 
-1.044 
Lymphoma 17 4.04E-04 
Ulcerative colitis 13 
-0.696 
NA   
Pancreatic ductal 
adenocarcinoma 14 
-0.696 
Pancreatic neoplasms 60 0.4629 
Chronic myeloid leukemia 15 
-0.696 
NA   
22213236 
Hepatocellular 
carcinoma 
miR-21 
miR-31 
mir-122 
miR-221 
miR-222 
miR-145 
miR-146a 
miR-200c 
miR-223 
Colorectal cancer 1 
58.552 
Colorectal neoplasms 29 1.32E-03 
Breast cancer 2 
37.818 
Breast neoplasms 9 1.65E-05 
Hepatocellular carcinoma  
3 
37.821 Carcinoma, 
Hepatocellular 2 9.70E-07 
Pancreatic cancer 4 
32.183 
Pancreatic Neoplasms 3 1.83E-06 
Prostate cancer 5 
20.947 
Prostatic neoplasms 5 3.97E-06 
Lung cancer 6 
16.732 
Lung neplasms 45 1.06E-02 
Glioblastoma 7 
13.547 Glioblastoma 30 1.32E-03 
Bladder cancer 
8 
4.427 Urinary Bladder 
Neoplasms 80 0.1046 
Gastric cancer 9 
6.355 
Stomach neplasms 4 2.73E-06 
Cardiac hypertrophy 
10 
3.549 Cardiomaypathy, 
Hypertrophy 75 0.0651 
Oral Squamous Cell 
Carcinoma (OSCC) 11 
-1.185 
Carcinoma,Oral 28 1.32E-03 
Papillary thyroid carcinoma 
(PTC) 12 
6.702 Papillary thyroid 
carcinoma 18 2.46E-04 
Non-small cell lung cancer  
13 
6.169 Carcinoma,Non-small cell 
lung 90 0.2383 
Glioma 14 
4.941 Glioma 98 0.3489 
Chronic lymphocytic 15 
-1.021 
NA   
 11 
leukemia 
23641832 
Acute 
myocardial 
infarction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-1 
miR-134 
miR-186 
miR-208 
miR-223 
miR-499 
Hepatocellular carcinoma  1 
2.295 
Carcinoma,Hepatocellular 38 0.205 
Myocardial infarction 2 
4.222 Myocardial infarction 1 3.30E-04 
Cardiac hypertrophy 
3 
4.222 Cardiomaypathy,Hypertro
phic 3 8.80E-03 
Acute promyelocytic 
leukemia  4 
0.185 
NA   
Retinitis pigmentosa (RP) 5 
1.762 
Retinal Degeneration 24 0.0859 
Cardiomyopathy 6 
1.762 Cardiomyopathy,Dilated 11 0.0221 
Lung cancer 7 
1.762 
Lung Neoplasams 4 0.0101 
Limb-girdle muscular 
dystrophies types 2A  8 
-1.044 
NA   
Head and neck squamous 
cell carcinoma (HNSCC) 9 
-1.044 
Head and neck neoplsams 
17 0.0388 
Endometriosis 10 
-1.044 Endometriosis 16 9.03E-03 
Chronic lymphocytic 
leukemia  11 
2.111 Leukemia,Lymphocytic, 
Chronic B-cell 41 0.3318 
Colorectal cancer 12 
-1.044 
NA   
Nemaline myopathy (NM) 13 
-1.044 
Distal Myopathis 14 0.033 
Lupus nephritis 14 
-1.044 
NA   
Myeloproliferative disorder 15 
-0.696 NA   
 
 
 
 
 
 
 
 
 
 
 
23272653 
Serous epithelial 
ovarian cancer 
 
 
 
 
miR-182 
miR-200b 
miR-200a 
miR-200c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Breast cancer 1 7.585 NA   
Ovarian cancer 2 
7.050 Ovarian Neoplasms 18 1.00E-02 
Hepatocellular carcinoma  3 
3.015 Carcinoma,Hepatocellular 17 1.00E-02 
Lung cancer 4 
0.207 
Lung Neoplasams 41 0.5392 
Epithelial ovarian cancer  5 
-3.828 Ovarian Neoplasms 18 1.00E-02 
Malignant melanoma 6 
-3.828 
Melanoma 12 1.35E-03 
Cancer 7 
0.022 
Carcinoma 4 3.17E-05 
Kidney cancer 8 
-2.784 
Carcinoma,Renal cell 19 0.0126 
Oral Squamous Cell 
Carcinoma (OSCC) 9 
1.947 
NA   
Non-alcoholic fatty liver 
disease 10 
-2.088 
Fatty liver 20 0.0221 
Endometriosis 11 
-2.088 Endometriosis 16 9.03E-03 
Serous ovarian cancer 12 
-2.088 Ovarian Neoplasms 18 1.00E-02 
Colorectal cancer 13 
-1.740 
NA   
Psoriasis 15 
-1.044 
NA   
  
 
   
23391324 
Acute myeloid 
leukemia 
 
miR-339 
let-7d 
miR-150 
miR-342 
let-7b 
miR-523 
 
 
 
 
 
 
Lung cancer 2 -0.163 Lung Carcinoma 22 0.1439 
Cardiac Hypertrophy 1 
1.415 
NA   
Colorectal cancer 3 
-1.392 Colorectal Neoplasms 11 0.2292 
Hepatocellular carcinoma  4 
-1.044 Hepatocellular carcinoma 6 0.099 
Neurodegeneration  
5 
-1.044 Neurodegenerative 
Disease 31 0.0509 
Multiple myeloma (MM) 6 
-1.044 Multiple myeloma 27 0.0721 
Primary biliary cirrhosis  7 
-1.044 
NA   
Limb-girdle muscular 
dystrophies types 2A 8 
-0.696 
NA   
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Non-small cell lung cancer  9 
-0.696 Lung Carcinoma 22 0.1439 
Uveal melanoma 10 
-0.696 
Melanoma 26 0.0245 
Nemaline myopathy 11 
-0.696 
NA   
Cervical cancer 12 
-0.696 
NA   
Serous ovarian cancer 13 
-0.696 
Ovarian Neoplasms 32 0.099 
Acute lymphoblastic 
leukemia 14 
-0.696 Leukemia, Myeloid, 
Acute 21 0.2593 
Papillary thyroid carcinoma 15 
-0.696 
NA   
23178446 
Clear cell renal 
cell carcinomas 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-514 
miR-122 
miR-141 
miR-155 
miR-184 
miR-200c 
miR-210 
miR-224 
 
 
 
 
 
 
 
 
 
 
 
Breast cancer 1 
13.549 
Breast neoplasms 48 0.3483 
Hepatocellular carcinoma  2 
11.438 Carcinoma Hepatocellular 5 4.57E-03 
Lung cancer 3 
5.821 
Lung Neoplasams 45 0.2846 
Diffuse large B-cell 
lymphoma  4 
7.564 Lymphoma,Large B-cell 
,Diffuse 13 0.033 
Pancreatic ductal 
adenocarcinoma  5 
2.829 
Pancreatic Neoplasms 8 0.0144 
Prostate cancer 6 
1.599 
Prostatic Neoplasms 52 0.5016 
Pancreatic cancer 7 
6.334 
Pancreatic Neoplasms 8 0.0144 
Cancer 8 
3.524 
Carcinoma 6 7.40E-03 
Malignant melanoma 9 
-2.784 Melanoma 27 0.0906 
Kidney cancer 10 
-2.784 
Carcinoma Renal cell 1 5.94E-05 
Epithelial ovarian cancer  11 
-2.436 
Ovarian Neoplasams 15 0.0403 
Colorectal cancer 12 
-2.088 
NA   
Oral Squamous Cell 
Carcinoma 13 
-0.511 
Carcinoma,Oral 35 0.1559 
Head and neck squamous 
cell carcinoma 14 
-1.740 
NA   
Ovarian cancer 15 
-1.740 
Ovarian Neoplasams 15 0.0403 
23427895 
Papillary thyroid 
carcinoma 
 
miR-99b 
miR-146b 
miR-146 
miR-221 
miR-222 
miR-375 
miR-551b 
miR-181 
 
 
 
 
 
 
 
 
 
 
Prostate cancer 
1 
8.977 
Prostatic Neoplasms 4 0.0117 
Pancreatic cancer 2 
8.096 
Pancreatic Neoplasms 19 0.01865 
Papillary thyroid 
carcinoma  3 
5.288 
Thyroid Neoplasms 8 0.0547 
Breast cancer 4 
2.828 Breast Neoplasms 24 0.3627 
Hepatocellular carcinoma  5 
5.986 Carcinoma Hepatocellular 6 0.02 
Pancreatic ductal 
adenocarcinoma 6 
1.947 
Pancreatic Neoplasms 19 0.01865 
Glioblastoma 7 
3.524 
Glioma 11 0.0904 
Coronary artery disease 8 
3.524 
NA   
Facioscapulohumeral 
muscular dystrophy 9 
-2.436 
NA   
Dermatomyositis 10 
-2.436 NA   
Nemaline myopathy 11 
-2.436 
NA   
Miyoshi myopathy (MM) 
12 
-2.436 Mascular Disorders 
Atrophic 1 7.72E-03 
Limb-girdle muscular 
dystrophies types 2A 13 
-2.436 
NA   
Polymyositis  14 
-2.436 
NA   
Glioma 15 
-2.088 
Glioma 11 0.0904 
 miR-26b Colorectal cancer 1 32.166 Colorectal neoplasms 26 0.034 
 13 
23207443 
Lung cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-21 
miR-451 
miR-486 
miR-205 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatocellular carcinoma  2 18.821 Carcinoma Hepatocellular 75 0.5373 
Pancreatic cancer 3 20.748 Pancreatic Neoplasms 48 0.0777 
Breast cancer 4 19.517 Breast Neoplasms 9 6.65E-03 
Lung cancer 5 
18.287 Lung Neoplasms 35 0.0401 
Prostate cancer 6 
10.556 
Prostatic Neoplasms 13 0.0105 
Glioblastoma 7 
9.675 Glioblastoma 6 2.09E-03 
Cardiac hypertrophy 
8 
5.289 Cardiomaypathy,Hypertro
phy 29 0.0366 
Bladder cancer 
9 
4.058 Urinary Bladder 
Neoplasms 27 0.034 
Esophageal cancer 10 
5.985 Esophageal Neoplasms 49 0.0807 
Non-small cell lung cancer  
11 
5.984 Carcinoma,Non-small cell 
Lung 3 2.06E-04 
Gastric cancer  12 
6.333 
Stomach Neoplasms 73 0.4222 
Head and neck squamous 
cell carcinoma  13 
4.754 
Head and neck  carcinoma 
23 0.0268 
Glioma 14 
6.333 Glioma 22 0.0188 
Oral Squamous Cell 
Carcinoma  15 
1.947 
Oral Carcinoma 
49 0.1316 
23617747  
Breast cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-9 
miR-200c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Breast cancer 1 
6.682 Breast Neoplasms 11 0.0403 
Cancer 2 
1.762 
Carcinoma 20 0.1494 
Lung cancer 3 
-0.696 Lung Neoplasms 28 0.3206 
Oral Squamous Cell 
Carcinoma  4 
-0.696 
NA   
Kidney cancer 5 
-0.696 
Carcinoma, Renal cell 16 0.0939 
Non-alcoholic fatty liver 
disease 6 
-0.696 
NA   
Epithelial ovarian cancer  7 
-0.696 
Ovarian Neoplasams 3 0.02 
Melanoma 8 
-0.696 Melanoma 10 0.0374 
Colorectal cancer 9 
-0.696 
NA   
Malignant melanoma 10 
-0.696 Melanoma 10 0.0374 
Testicular germ cell tumor 11 
-0.696 
Prostatic Neoplasms 26 0.2064 
Lupus nephritis 12 
-0.696 
NA   
Ovarian cancer  13 
-0.696 
Ovarian Neoplasams 3 0.02 
Serous ovarian cancer 14 
-0.696 
Ovarian Neoplasams 3 0.02 
Endometrial cancer 15 
-0.696 Endometrial Neoplasms 8 0.033 
22768114 
Myotonic 
dystrophy type-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-378a 
miR-34a 
miR-34b 
miR-34c 
miR-146b 
miR-208a 
miR-221 
miR-381 
miR-125b 
miR-193a 
miR-193b 
Pancreatic cancer 1 
8.281 
Pancreatic Neoplasms 8 1.30E-03 
Malignant melanoma 2 
1.088 Melanoma 14 5.02E-03 
Colorectal cancer 3 
2.133 
Colorectal neoplasms 4 1.47E-04 
Neuroblastoma 4 
5.637 Neuroblastoma 61 0.2175 
Hepatocellular carcinoma  5 
5.637 Carcinoma Hepatocellular 34 0.0406 
Prostate cancer 6 
5.638 
Prostatic Neoplasms 6 1.96E-04 
Non-small cell lung cancer  
7 
-0.326 Carcinoma Non-small cell 
lung 66 0.2612 
Melanoma 8 
0.022 Melanoma 14 5.02E-03 
Breast cancer 9 
0.022 NA   
Papillary thyroid carcinoma  
10 
0.022 Papillary thyroid 
carcinoma 32 0.0367 
 14 
 
 
 
 
 
 
 
 
 
 
 
 
Duchenne muscular 
dystrophy  11 
-3.132 Muscular Disorders, 
Atrophic 15 7.72E-03 
Ovarian cancer 12 
-1.207 NA   
Chronic lymphocytic 
leukemia  13 
1.947 Leukemia,Lymphocytic,C
hronic,B-cell 5 1.70E-04 
Oral Squamous Cell 
Carcinoma 14 
-2.784 
Carcinoma,Oral 10 1.85E-03 
Glioma 
15 
-2.436 
Glioblastoma 
73 0.4804 
 
 
Supplementary Table S3: Evaluation of Gene-Disease tool of miRegulome v1.0 using ten sets of 
genes for various diseases taken from ten different PubMed articles that are not curated for this version 
of miRegulome. 
 
PMIDs Set of  Genes Disease 
association in 
PMID 
miRegulome 
tool 
miRegulome 
predictions 
miRegulome 
ranks 
miRegulome 
Association 
scores 
19951989 
 
RSF1, DYRK2, YY1, 
C19orf12, THEM2, TRIO, 
MYADM, BAIAP2, ROGDI, 
DNAJB14, BRE, TMEM41A, 
C9orf64, FAM110A, PCNXL2, 
REST, C19orf62, C13orf27, 
ASCC3, SLC1A5, PTPLAD1, 
MRE11A, GTPBP10, 
BX118737, SERPINI2, 
CREB1, CCDC53, USP48, 
ZSCAN2 
Non-Small-Cell 
Lung Cancer 
Gene-Disease Lung cancer 5 215 
21610147 
 
APC, CDH1, MGMT, DCC, 
RASSF1A, AIM1 
Lung cancer Gene-Disease Lung cancer 5 142 
23533275 ACTR3B, APOC1, ATP8A1, 
C10orf116, Cdk1, CDON, 
DEGS1, SYMN, DPP4, F12, 
FEV, GATA3, GSTM3, 
HIST1H3H, HOXC4, 
TMEM132A, IGSF1, IGSF6, 
INHBA, KRT15, LDHB, 
KIF18B, NCAPG2, MAOA, 
MT1F, OIP5, PPP3CB, QPRT, 
TPX2 
Prostate cancer Gene-Disease Prostate cancer 8 62 
23536436 CD36, DHRS13, DUSP2, 
FAM198B, FKBP5, GLT25D2, 
GZMB, IL1B, ITGAM, 
ITPRIPL2, MYBL1, NEAT1, 
NUDT16, P2RY10, PDE4D, 
PDZK1IP1, SH2D2A, VSIG10 
Colorectal 
cancer 
Gene-Disease Colorectal cancer 1 292 
23599765 MYF6, SIX6, SOX1, RARB, 
BCL2, PHOX2A, FOLX2 
Non-small cell 
lung cancer 
Gene-Disease Lung cancer 7 256 
23606240 COL2A1, ATP4B Gastric cancer Gene-Disease Colorectal cancer 1 99 
23591077 CLDN1, CLDN10, MMP2, c-
fos 
Lung cancer Gene-Disease lung cancer 6 39 
23651824 XPO1, GABPB2, RANBP17, 
KALRN, XPO5 
Heart failure Gene-Disease Cardiac 
hypertrophy 
10 27 
23648477 FGF18, BCL2, PRC1, MMP9, 
SERF1a 
Breast cancer Gene-Disease Breast cancer 4 380 
21733826 TP53, CTAG1B, CAGE, 
ANNX, SOX2 
Lung cancer Gene-Disease Lung cancer 6 387 
 
